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Abstract
Assessment of tissue regeneration is essential to optimize the stages of tissue engineering (cell proliferation, tissue development
and implantation). Optical and X-ray imaging have been used in tissue engineering to provide useful information, but each has
limitations: for example, poor depth penetration and radiation damage. Magnetic resonance imaging (MRI) largely overcomes
these restrictions, exhibits high resolution (approximately 100 μm) and can be applied both in vitro and in vivo. Recently, MRI
has been used in tissue engineering to generate spatial maps of tissue relaxation times (T1, T2), water diffusion coefficients, and
the stiffness (shear moduli) of developing engineered tissues. In addition, through the use of paramagnetic and superparamagnetic contrast agents, MRI can quantify cell death, assess inflammation, and visualize cell trafficking and gene expression. After
tissue implantation MRI can be used to observe the integration of a tissue implant with the surrounding tissues, and to check for
early signs of immune rejection. In this review, we describe and evaluate the growing role of MRI in the assessment of tissue engineered constructs. First, we briefly describe the underlying principles of MRI and the expected changes in relaxation times (T1,
T2) and the water diffusion coefficient that are the basis for MR contrast in developing tissues. Next, we describe how MRI can be
applied to evaluate the tissue engineering of mesenchymal tissues (bone, cartilage, and fat). Finally, we outline how MRI can be
used to monitor tissue structure, composition, and function to improve the entire tissue engineering process.
Keywords: tissue engineering, regenerative medicine, magnetic resonance imaging (MRI), elastography, organogenesis, bone, fat,
cartilage, mesenchymal stem cell

Approximately one person in five in the United States
will require organ replacement therapy before reaching 65
years of age (1). Physicians now treat organ failure either by
surgically transplanting tissues or by replacing living tissue
with mechanical/electrical devices such as artificial joints,
vascular stents, or pacemakers. However, transplants rely on
the availability of a compatible donor while biomechanical
devices wear out and must be replaced. Tissue engineering
provides a third option for patients; an option that is the focus of regenerative medicine. In regenerative medicine new
sources of replacement tissues are used, sources that are not
surgically transplanted, but assembled de novo from a threedimensional porous scaffold imbedded with stem cells and
essential growth factors. Directing this process is possible
only if the tissue engineer has a clear picture of all the individual components: cells, extracellular matrix, and biochemical growth modulators. Optical and fluorescent microscopy
can be used to monitor tissue growth, but even multi-pho-

ton techniques have a limited depth of field—generally up
to hundreds of microns or one millimeter (2). Micro-CT
solves the penetration problem but uses ionizing radiation
and requires dense tissue to provide contrast (3). Much current interest is directed towards magnetic resonance imaging (MRI), which uses non-ionizing radiation and has the capability of imaging thin slices of tissue in any orientation, at
any depth, and with submillimeter resolution.
As tissues grow, morphogenesis alters their physical and
chemical properties. Changes in tissue hydration, macromolecular content, or water/lipid ratios, for example, are reflected in MRI as contrast in phase, diffusion, or relaxation
time weighted MR images. In addition, high resolution MRI
(slices less than 100 μm) can be used to characterize the structure and composition of regenerating tissues with resolution approaching that of individual cells, with the aid of high
field systems above 7 T. Current applications of MRI in tissue engineering span a range from the investigation of mes515
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Figure 1. A flow diagram for bone tissue engineering. After isolation from bone marrow, mesenchymal stem cells (MSCs) are allowed to proliferate in vitro. The cells are then seeded into the biocompatible scaffold along with growth and differentiation factors (for example, β-glycerophosphate and ascorbic acid). The cells continue to grow and differentiate in an incubator or bioreactor. Upon maturity, the engineered tissue is transplanted into the animal or patient.

enchymal stem cell differentiation in culture and bulk cell
expansion in bioreactors to studies in whole animals monitoring the growth of implanted bone, fat, or cartilage tissues.
In order to better understand the role of MRI in tissue engineering and regenerative medicine, this review will: (i) describe the physical basis for MR contrast in developing tissues, (ii) highlight recent MRI studies of tissue engineered
constructs, and (iii) outline new areas for future research and
development.
Principles of tissue engineering
Tissue engineering seeks to create biological substitutes
that restore, replace, or regenerate defective tissues and their
function (4, 5). Successful tissue engineering requires healthy
expandable cells, a porous biocompatible scaffold, biochemical growth factors, and a favorable physiological environment for tissue regeneration (6, 7). Cell sources, based on
their origin, fall into three categories: autologous cells from
the patient, allogeneic cells from another human donor, and
xenogeneic cells from other species. Each cell source ultimately is derived from either embryonic stem cells or adult
differentiated stem cells (4). Differentiated adult stem cells
have the shortcoming that only a limited number of cells can
be harvested from the patient, and harvesting cells causes
trauma and tissue damage. These shortcomings have limited
the clinical application of adult differentiated stem cells (8).
On the other hand, embryonic stem cells, with proper induction, can differentiate into many tissues (mesenchymal stem
cells, for example, into fat, bone, cartilage, muscle, ligament,
tendon, and marrow stroma), and following in vitro culture
and expansion can potentially provide an unlimited supply
of cells for tissue transplantation. Current medical practice
could use engineered tissues to treat a variety of diseases (for
example, skin ulcers, joint defects, diabetes, cardiac valve
failure, osteogenic tissue loss, and liver disease) (9, 10). However, before clinicians can apply engineered-tissues in regenerative medicine, the ethical and practical issues of human
embryonic stem cells must be resolved, and the procedures
for stem cell collection, expansion, differentiation and implantation must be perfected. In this paper we will show
how magnetic resonance imaging (MRI) can be used to en-

hance tissue engineering through improved monitoring of
cell growth and tissue development.
The strategy for using mesenchymal stem cells in tissue
engineering is illustrated in Figure 1 for a bone replacement
implant in a mouse. Following the successful collection of
cells from donor bone marrow, the cells are expanded in cell
culture and either compacted into a pellet or seeded into an
artificial scaffold. Scaffolds are typically fabricated from natural-derived (for example, agarose, alginate, or collagen) or
synthetic biomaterials (for example, polymers such as polyglycolic acid or hydrogels). The scaffold provides a bioactive
framework for cell proliferation and differentiation. Scaffolds
must have a high ratio of cell accessible space to total volume
(diffusivity, porosity), with pore sizes greater than 10 microns to facilitate cell seeding and the diffusion of nutrients.
In addition, the scaffold should exhibit sufficient mechanical
strength to support the surrounding tissues, initially at the
time of transplantation, and subsequently for the duration of
the healing process. Finally, proper tissue development requires biodegradability of the scaffold and the timely application of tissue differentiation and growth stimulation factors. This entire process typically begins with cells growing
in culture or in a specially designed bioreactor (for a period of
weeks) and then proceeds in the animal or patient for months
after implantation (11). In order to ensure optimal growth,
the tissue engineer needs regular feedback about the structure, composition, and strength of the developing tissues. In
the following sections, we describe how such information can
be acquired using MRI for tissue engineered bone, cartilage
and fat, but first we will summarize the basic principles underlying MRI and the key parameters that affect image quality, resolution and contrast.
Principles underlying image contrast in MRI
MRI is a sensitive method for visualizing structural and
functional changes in biological tissues (12). For example,
as tissues develop, die, or regenerate, the local environment
of the tissue water—the source of the MR signal—changes.
Such changes are reflected in MR images through local variations in the amount of tissue water, its physical state (e.g.,
freely diffusing or protein bound), and its nuclear magnetic
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Figure 2. The block diagram of a typical MRI system with the components, pulse sequence and image display highlighted. When an animal, human
or tissue sample is placed in a magnetic field (B0), the magnetic moment of the protons in the nucleus of the hydrogen atoms of the water precess at
a frequency dependent upon the strength of the magnetic field, f0 = γβ0/2π where γ/2π = 42.57 MHz/Tesla for hydrogen; f0 for protons is typically
in the range of 50–500 MHz. The magnetic moments align in a direction parallel to the main field establishing a net magnetization in the tissue water. A radio frequency (RF) coil produces a B1 field that changes the direction of the magnetization in a manner prescribed by the pulse sequence
(for example, 90° and 180°). Following the RF pulses, the radio frequency coil detects the return of the magnetization to thermal equilibrium. Spatial
localization is generated with the use of the gradient coils (Gx, Gy, Gz). Variation of the repetition time (TR) and the echo time (TE) in the MR pulse
sequence provides the basis for different contrast mechanisms. For example, a long TR and a short TE will produce a T1 weighted image based on
the MR properties of the imaged sample. Other conditions can generate T2, proton density or diffusion weighted images. The MR signal is acquired
as a complex quantity (magnitude and phase). The magnitude is sufficient to depict anatomical features, measure tissue relaxation times or estimate
the apparent water diffusion coefficient, while the phase can be used to measure blood flow, tissue temperature and tissue stiffness.

resonance (NMR) relaxation times (T1 and T2). The dynamics of these changes in tissue water are captured in MRI by
the Bloch equation: a phenomenological equation describing the physics of magnetic moments—such as the magnetic
moment of the water proton—as a precessional gyroscopic
motion in the presence of exponential damping (T1 and T2),
perturbing magnetic fields (the fixed, B0 and the time-varying radiofrequency, B1), and magnetic field gradients (Gx, Gy,
Gz). The reader is directed to the book “Magnetic resonance
imaging: physical principles and applications” by Kuperman
(13) for a concise description of the physics underlying the
Bloch equation and for a discussion of the prevailing techniques used to acquire and display MR images. Here we will
only illustrate the process diagrammatically (Figure 2) via
the connections between the MRI imaging system, the image
acquisition pulse sequence, and the reconstructed MRI image/display. MRI begins with selection of the pulse sequence
parameters in an imaging protocol (Figure 2) that specify the
field of view, signal-to-noise ratio and spatial resolution. The
pulse repetition time, TR, defines the time period over which
the tissue water can recover its observable magnetization;
the echo time, TE, is the time period after the initial radio
frequency pulse when the signal (echo) is recorded; and the
magnetic field gradient pulses (Gx, Gy, Gz) give spatial localization for the NMR signal in the sample. For the spin echo
sequence described in Figure 2, the signal intensity is proportional to the local water concentration multiplied by the exponential decay expression (1-e−TR/T1)e−TE/T2. Thus, changes
in tissue during growth that affect the amount of water or
change its T1 or T2, for fixed values of TR and TE, will alter the magnitude and phase of the detected MR signal. Re-

gions of the image exhibiting different signal intensities are
revealed as contrast in the image.
In a digital MR image, the field of view (FOV) for single
slice can be decomposed into individual picture elements
(pixels) that determine the resolution of the image. The relationship between pixels and FOV in the x and the y directions, for example, is simply: FOVx = NxΔx and FOVy =
NyΔy, where Nx and Ny are typically 128 or 256. Acquisition
of an MR image involves sampling the detected NMR signal
for each of the slices of the object under study. The mathematics of sampling requires the sampling intervals to be less
than two times the reciprocal of maximum frequency (Nyquist sampling criterion). This constraint gives the following
simple relationships between MR imaging parameters, and
the resolution for rectilinear sampling (13) for the spin echo
pulse sequence shown in Figure 2.
Δx = FOVx ÷ Nx = 2π ÷ Nx γ Gx Tacq

(1)

Δy = FOVy ÷ Ny = 2π ÷ Ny γ Gy Tpe

(2)

In these expressions γ/2π is the gyromagnetic ratio (42.58
MHz/T for water protons), Gx and Gy are the magnitude of
the x (read) and y (phase) encoding gradients (typically, 1–
200 G/cm), and Tacq and Tpe are the duration of the acquisition window (typically 1–10 ms) and the phase encoding
gradient (typically, ≤5 ms), respectively. From these equations it follows that stronger gradients (Gx, Gy, Gz) improve
the achievable resolution (typically 50 to 500 microns). The
slice location and thickness are determined by modulation of
the transmitted radio frequency pulses (B1 in Figure 2). For
the typical sinc pulse modulation the slice thickness is given
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by
Δz = 4π ÷ γ Gz τp

(3)

where τp is the duration of the 90° B1 pulse (typically 5 ms).
The signal-to-noise ratio (SNR) associated with MR imaging can be summarized by the expression
2

SNR µ B0 VsN

(4)

where B0 is the strength of static magnetic field, Vs is the volume of the sample and N is the number of acquisitions (14).
High field MRI (3 Tesla and above) thus directly improves
the SNR and allows faster imaging without compromising
the resolution. The ability to distinguish individual pixels in
a given MR image is known as contrast. Since image noise
often limits the achievable contrast, a figure of merit used
to characterize image contrast is the contrast to noise ratio
(CNR), defined for two tissue regions A and B as
CNR = (SNRA – SNRB) ÷ Noise

(5)

Contrast, thus depends on increasing the relative difference
between the signal intensities of two adjacent regions of an
image and reducing the overall noise level. The noise can be
estimated from the expression
Noise = (4kB T Δf R)1/2

(6)

where kB is the Boltzman’s constant, T is the absolute temperature, Δf is the detector’s frequency bandwidth and R is
the overall resistance of the loaded RF coil.
Optimal tissue contrast relies on selection of an appropriate imaging strategy to highlight the intrinsic differences between various tissues. Basic tissue contrast arises
from the relative abundance of the hydrogen nuclei under investigation, that is, water content, and the two relaxation times: spin-lattice relaxation T1 and spin-spin relaxation T2 (12). Advanced contrast methods include injection
of paramagnetic contrast agents such as Gd-DTPA, and the
use of MR techniques that are sensitive to water diffusion
in the tissue (13, 14). An example of current animal work
using contrast agents is the study by Ko and coworkers
(15), where the investigators demonstrated that MRI could
be used to monitor and track transplanted cells in vivo. In
this preliminary study human bone marrow-derived MSCs
were labeled with super paramagnetic iron oxide, a strong
T2 contrast agent. After the cells were embedded in a gelatin sponge the construct was implanted subcutaneously
at the right proximal thigh of a 6 week-old nude mouse.
MR images confirmed that cell labeling could be observed
in living animals; a critical first step in establishing in vivo
monitoring.
Methods to Enhance Image Contrast in MRI
Water, the principal source of the signal detected in MRI,
occupies multiple tissue compartments (for example, intravascular, extracellular, intracellular) where diffusion and
tissue heterogeneity modulate water’s complex interactions with proteins, macromolecules and membranes. Local changes in the bulk water distribution and the compart-
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mental T1 and T2 relaxation measurements do not always
give specific measures of tissue complexity; hence, other
techniques are needed to provide a complete picture of the
changing dynamics occurring during tissue growth. Diffusion weighted MRI, magnetization transfer (MT) contrast
and T1ρ relaxation, for example, are MR techniques that can
provide additional information about tissue structure and
composition. In addition, chemical shift imaging and MRIbased tissue elastography can be used to measure the chemical and physical properties, respectively, of individual tissue
compartments. Here we describe the basic principles underlying these advanced contrast methods in MRI. Additional
details can be found in the cited references.
Diffusion contrast — When implanted cells proliferate and
become organized into tissue the overall diffusion of water
decreases because the molecules encounter additional physical barriers (16). Diffusion weighted MRI provides a means
to identify the emerging tissue structure through the reduction of the apparent diffusion coefficient. The mechanism
underlying diffusion weighted imaging is the application
of a sequence of two short duration (δ) gradient pulses of
opposite polarity that are separated by a delay time (Δ). In
the absence of diffusion the two pulses induce small phase
shifts that compensate for each other, but when diffusion occurs the cancellation is incomplete and additional signal attenuation arises; typically the signal is attenuated according
to e−bD, where b = (γGzδ)2Δ for Δ>>δ and b is determined
from the area (Gzδ) and separation (Δ) of the applied gradient pulses. By stepping b over a range from 100 to 2000 s/
mm2 or higher the exponential signal decay can be plotted
and the apparent diffusion coefficient, D, determined for the
tissue (16). In isotropic, but heterogeneous tissue, D changes
with location but is independent of direction; hence, a single
value of D is sufficient to characterize the diffusion of each
voxel. When the tissue environment is anisotropic, however,
such as in white matter of the brain or in articular cartilage,
D is described by a 3×3 matrix or diffusion tensor (16). Diffusion weighted and diffusion tensor imaging are typically
conducted at submillimeter resolution, providing spatial
maps of the apparent water diffusion coefficient. In diffusion weighted MRI the diffusion data are often presented as
diffusion ellipsoids, which can be calculated for each voxel,
such that by their eccentricity and orientation the paths of
preferred diffusion can be identified (16).
Magnetization transfer contrast — Magnetization transfer
contrast depends on the exchange of magnetization between
the protons (H nuclei) of free water and water bound to proteins and other macromolecules (17). In this technique, an off
resonance radio frequency pulse is applied, which ideally
eliminates the signal associated with macromolecular water.
Subsequent interaction and exchange between the two water pools give a signal that reflects the distribution of macromolecules in the tissue—via the magnetization transfer ratio
(MTR). Magnetization transfer is currently used in MR angiography to attenuate the signal from brain tissue and to improve contrast between blood vessels and surrounding tissue (18). The MTR is also sensitive to the structural changes
that occur in cancer, arthritis and multiple sclerosis. For example, in a study by Brochet and Dousset (19), a reduction
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in the MTR was found in demylinated lesions, and that decrease was proportional to the level of myelin loss. In cartilage tissue engineering we would anticipate an increase in
MTR with the incorporation of collagen and proteoglycans in
developing cartilage (20).
T1r contrast — T1r is a relaxation parameter that is sensitive
to molecular processes occurring at a much lower frequency
range than those associated with T1 relaxation (kHz instead
of MHz). T1r measurements are essentially T1 measurements
performed while the radio frequency B1 pulse is left on for
the entire relaxation period. T1r values reflect the macromolecular content of the tissue more strongly than T1 relaxation
times. T1r contrast arises, for example, when the collagen matrix is disrupted in diseased cartilage. In a recent study of
cartilage, for example, a statistically significant change in T1r
was observed between native and enzymatically treated cartilage (21). Changes of T1r were also observed in proteoglycan-depleted cartilage, indicating T1r sensitivity to proteoglycan content (22).
Chemical shift — Chemical shift imaging separates signals
from each chemical component in a tissue (23). The separation is based on the small difference between the individual
resonance frequencies for hydrogen atoms associated with
water or with lipids. For example, between fat lipids and water, there is a frequency shift of approximately 450 Hz (at 3.0
T). By applying frequency selective radio frequency pulses
it is possible to excite individual hydrogen nuclei in tissue.
Since the methylene (-CH2-) group is typically associated
with fat while the surrounding water contain free and bound
water the two pools can be separated by their characteristic frequencies. Thus, chemical shift imaging provides separate images for each tissue component. Chemical shift imaging can also be used either to suppress the fat signal in MRI
or to highlight the development of adipose tissue in tissue
engineering.
Magnetic resonance elastography — Stiffness or elasticity
is an intrinsic mechanical property of biological tissues that
changes in disease, with recovery from injury, and as tissue regrows or regenerates. Magnetic resonance elastography provides maps of tissue stiffness from the analysis of a
phase contrast MR image acquired while applying a low frequency mechanical shear wave (typically with amplitudes of
less than 100 μm and frequencies of 100–1000 Hz). The periodic vibrations are synchronized with the MR image acquisition (24) and motion encoding gradients stepped in sequence
to provide shear wave motion images that can be analyzed
to extract tissue elasticity maps (stiffness and viscosity). Bulk
elastic parameter data can be used to assess developing pathology and tissue regeneration. For example, in the recent
study by Cheung and associates, MR elastography was used
to observe changes in the shear modulus of plantar fat pads
in diabetics (25).
Bone Tissue Engineering
Trauma, osteoporosis, and cancer lead to over two million cases of bone injury or loss in the United States each
year (26). Natural bone healing following injury or disease
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is the preferred option to overcome osteogenic tissue loss
and bone damage. However, since bone has a limited capability to regenerate and remodel, it is often the case that the
surgeon will need to implant synthetic materials or bone
grafts at the site of injury. Approximately one million cases
of bone grafting are performed each year in the United
States to treat non-union following fracture, at an estimated
cost of over $3 billion per year (26). Both autologous and allogeneic bone grafts are used clinically as bone substitutes;
however, the availability of compatible bone grafts is limited because harvesting bone is painful and the procedure
carries the risk of infection. Therefore, alternative tissue
sources are needed.
Bone is a dense connective tissue with a strong calcified
outer layer (cortical bone) that comprises more than three
fourths of the bone mass. Cortical bone has a relatively low
porosity, ranging from 5% to 10% (porosity is a measure of
the available fluid volume of bone, and can be determined
from the ratio of dry to fresh, wet bone weight). The soft inner spaces of bone (usually described as cancellous or trabecular bone) form the remaining one fourth of the bone mass.
Cancellous bone has a high porosity (ranging from 60% to
90%) and contains the bone marrow, which consists of blood
stem cells, adipose cells, osteoblasts, and osteocytes. Osteoblasts are essential for the deposition and mineralization of
the extracellular matrix of new bone while osteocytes are the
supporters for bone matrix calcification. Specific growth factors and proteins, mainly residing in the extracellular matrix
of bone, are responsible for regulating cellular activity and
stimulating the intracellular environment. The factors and
proteins that the tissue engineer must control include transforming growth factor-beta (TGF-beta), insulin-like growth
factors (IGF) I and II, fibroblast growth factor (FGF), and
bone morphogenetic proteins (BMPs) (27).
Replacing the natural repair processes in bone is the goal
of bone tissue engineering. To achieve this goal a source of
bone forming cells must be found and a means of physically supporting these cells in a structural scaffold developed. Bone marrow stromal cells, also called mesenchymal
stem cells (MSCs), can be stimulated to differentiate into osteoblasts, chondrocytes and adipocytes, and thus they can
provide a potential source for bone progenitor cells (28).
Biocompatible scaffolds of bone tissue engineering should
be mechanically stiff, porous, and moldable (28). Commercially available bone scaffolds vary in composition, spanning a range that includes ceramics, metals, polymers, and
natural materials (26). Natural biodegradable polymers
are often used because they integrate most easily with surrounding tissues (28). Researchers have been successful
using MSCs to regenerate bone in bioreactors, in animal
models and in clinical trials. X-ray and micro-CT imaging
techniques are most suitable for viewing solid bone growth,
but early bone tissue development can be monitored using
conventional MRI and the new ultra short TE methods, under development (29).
MRI of bone — Cortical bone is not visible in conventional
MRI. Bone appears dark because of the relatively low number of hydrogen atoms in the bone mineral and the very short
T2 relaxation time of the solid material: cortical bone has an
average T2 of 250–500 μs (30). Bone can be imaged, using ul-
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Figure 3. (A) An illustration of the anatomical structure of a long and cancellous bone, and a T1-weighted axial MR image (field strength = 11.7 T;
spin echo sequence TR/TE = 500 ms/7 ms, slice 1 mm) through a cylindrical osteochondral plug excised from the distal femoral condyle. (B) T1/
T2 bar chart and high resolution axial MR images for tissue engineered bone (33) over a 4-week period. The relaxation time data show that T2 is
a good marker for studying the development of the construct while T1 is less sensitive. The high resolution images were acquired with acquisition parameters: TR = 1 s; TE = 30 ms; slice thickness = 0.5 mm; field of view (FOV) = 0.8 cm × 0.8 cm; in-plane resolution = 62.5 μm × 62.5 μm; and
number of averages N = 8. The MR images show the consolidation of the construct (diameter decreases by 50%) and a fall in overall signal intensity with the incubation time. Relaxation times are represented by average ± std (sample size n = 7).

trafast MR imaging sequences that capture the data quickly
(in less than 1 ms after excitation), but such techniques are
not widely available and require special high speed imaging
hardware (30, 31). Therefore, the predominant features visible in MR images of bone reside in the bone marrow (Figure 3). Contrast in the bone marrow reflects the micro-architecture and its fat/water composition. However, special care
must be taken when viewing the interface between the marrow and the surrounding solid bone tissue where the transition between the marrow and cortical bone can induce magnetic field artifacts and distort the MR image.
Progress in monitoring tissue-engineered bone in vitro —
X-ray micro-tomography (micro-CT) of cortical bone exhibits
high resolution and contrast; however, the X-ray contrast is
less apparent in the marrow and in newly formed bone prior
to mineralization. Thus, MRI, with its superior soft tissue
contrast, can be expected to provide greater detail in images
of the beginning stages of bone growth. Such results were in
fact observed in an in vitro study comparing micro-CT and
9.4 T MRI by Washburn and coworkers (32). In this study
of bone formation a porous polyethylmethacrylate scaffold
was seeded with primary chick osteoblasts. Growth was assessed over an 8 week period by following the loss of MR
signal in proton density MR images and the appearance of

solid bone contrast in the micro-CT images. A similar progressive decrease in the MR signal was observed by Xu and
coworkers (33) in a 4-week study of osteogenesis by MSCs
embedded in a gelatin scaffold. Xu used 11.7 T MRI to monitor bone formation and found a linear relationship between
the concentration of bone minerals, such as calcium, and the
T1 and T2 relaxation times. In Xu’s study the T2 was reduced
by over 50% as the bone developed (Figure 3); a T2 decrease
similar to that observed by Washburn and coworkers (32).
In both the Xu and the Washburn studies the observed decrease in relaxation times correlated with bone mineral deposition—as measured by histological analysis (calcium
composition and alkaline phosphatase activity). Also, both
groups reported that the apparent diffusion coefficient decreased, likely reflecting the increase in structure (interfaces
and barriers to diffusion) of the engineered bone tissue. On
the other hand, in another bone growth study using MR microscopy at 9.4 T Chesnick and associates (34) found that the
T2 values increased. This research monitored mineralization
in a hollow fiber bioreactor seeded with embryonic chick osteoblasts. Proton density MR images as well as T2 relaxation
time and magnetization transfer ratio maps were obtained
with a 78 μm resolution for 1 mm slices. The magnetization transfer ratio was found to change with mineralization
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in bone constructs, that is, higher values were observed in
the mineralized zone and non-uniform but lower values in
the superficial region. These results illustrate the complexity of monitoring bone formation in different systems, hence
the need for MR microimaging, quantitative parameter measurements and histological controls.
An important measure of bone development is mechanical strength. MR elastography is able to assess tensile
strength through measurements of bone stiffness and elasticity. In a study of bone development by Othman and coworkers (35), MR elastography was used to characterize the early
stages of bone formation in gelatin scaffolds embedded with
MSCs. This study measured the shear stiffness of developing bone over a two week period. Compared with controls,
a three- to fourfold increase in shear stiffness was reported
during the initial stages of growth: 11.88±0.4 kPa at week
1 and 15.8±0.5 kPa at week 2 for the treated groups (compared with 4.1±0.3 kPa at week 1, and 3.6±0.4 kPa at week
2 for controls). Othman’s study also revealed a non-uniform
growth of bone components within the sample, and considerable variation of the MR parameters from region to region.
Such results could reflect either non-uniform seeding of stem
cells in the scaffold or a problem with the distribution of nutrients and growth factors.
Progress in monitoring tissue-engineered bone in vivo —
As in vitro tissue engineering methods are perfected there
will be an increasing need for in vivo monitoring of implants,
first in animals and later in human clinical trials. In an animal study by Hartmen and associates (36), MRI was used
to assess the growth and development of bone. Using a rat
model, Hartmen employed high resolution MRI at 7.1 T to
monitor ectopic bone formation over a 7-week period. The
post-implantation MR and X-ray images, and histological results, confirmed that MRI could detect small changes in bone
growth (0.5 mm in diameter), as well as display the complete 3D shape of the newly formed bone. In another bone
growth study using an athymic mouse model, Potter and coworkers (20) used MR microscopy to evaluate the growth
and development of tissue engineered phalange constructs.
MR microscopy images at week 38 showed the engineered
specimen to be about 3 mm longer and more heavily mineralized than controls. In this study, an inverse linear relationship was found between mineral concentration measured by
X-ray micro-CT and tissue hydration as measured by MR microscopy at 9.4 T. Such animal studies show that MRI can be
used to monitor the progressive changes of engineered bone
that occur over a period of months and that MRI can serve as
a complement to micro-CT (37).
Cartilage Tissue Engineering
A major degenerative disease of articular cartilage is osteoarthritis. Osteoarthritis affects approximately 70 million people in the United States and is the leading cause of
chronic disabilities in people over 50 years of age (38). The
cost of treating arthritis and related conditions in the United
States is over 65 billion dollars per year (39). Current cartilage restoration therapies rely on either tissue grafts or engineered cartilage substitutes. Replacement tissue grafts (autografts or allografts) have a success rate of approximately 70%
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after two to five years (40). However, cartilage grafts have
the common shortcomings of all transplant therapies: donor availability, donor site morbidity (due to excessive tissue
loss) and the possibility of pathogen transmission (39). Engineered cartilage substitutes, when fully developed, have the
potential to overcome these limitations.
Articular cartilage is a thin heterogeneous tissue with a
thickness typically less than 2 mm that coats skeletal joint
surfaces. Cartilage consists of collagen—mostly in the form
of type II collagen—and proteoglycans. Articular cartilage
has four distinct zones: the superficial zone with collagen fibrils oriented along the cartilage surface (approximately 5–
10% of thickness in humans), the transitional zone with
randomly oriented collagen (approximately 40–45% of thickness), the radial zone with radially oriented collagen (approximately 40–45% of thickness), and the deepest calcified
zone, which has little collagen and acts as a transition region
between the soft hyaline cartilage and the stiffer subchondral
bone (approximately 5–10% of thickness). Each of the four
zones has different biomechanical properties that are consistent with their structure and function (41).
Cartilage tissue engineering has the goal of reestablishing
the natural state in damaged cartilage. The process first involves introducing progenitor cells into the injured site, with
or without a scaffold. The best source of cells for cartilage repair is an area of active investigation; both chondrocytes and
stem cells are widely used in cartilage tissue engineering.
The primary advantage of chondrocytes is that they immediately begin to secrete cartilage-specific extracellular matrix
components and thus can more rapidly form cartilage-like
tissue (<2 months) (39, 40). In orthopedic clinics, implantation of a suspension of cultured autologous chondrocytes is
becoming an established technique for the treatment of joint
surface defects of the knee. However, despite promising clinical results, the use of chondrocytes has some limitations,
principally due to the low expandability of chondrocytes and
the complexity of biological responses in the periosteum (8).
A large number of donor cells are needed to repair a large
cartilage defect, but these cells are often not available. In contrast, MSCs are relatively easy to harvest, and are expandable from small quantities in vitro in cell culture, and can be
induced to differentiate into chondrogenic cells (39). Therefore, chondrogenic cells derived from MSCs are a promising
choice for developing cartilage regeneration.
Even though cartilage is a relatively simple tissue with a
low cell density, limited cell diversity and the absence of vascular structure or nerve supply, so far, tissue engineering techniques have not succeeded in producing an implant capable of
functioning in vivo at the joint surface (42). One problem facing tissue engineers is the selection of an appropriate biological scaffold. Natural and synthetic scaffolds are available in
various physical forms, and compared with natural materials,
synthetic scaffolds are easily mass-produced and free from the
risks associated with pathogen transmission. Solid polymers
such as polyglycolic acid or composites, such as, hyaluronangelatin have also been successfully applied in chondrogenesis (43, 44). In addition, other groups are exploring hydrogels
(highly hydrated polymeric systems with tissue-like water
content) as a framework in which to encapsulate cells (45). To
date, naturally derived collagen, the major structural component of cartilage, has received the most attention, largely be-
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Figure 4. (A) An illustration of the anatomical structure of cartilage along with a high resolution MRI, and a histological image (Safranin-O/Fast
green-stained section [40×) of natural cartilage (48). In the MR image, three cartilage zones can be easily identified without contrast agent enhancement. The MR image acquisition parameters are: TR/TE = 1000/60 ms; field-of-view (FOV) = 0.6 cm × 0.6 cm; slice thickness = 0.5 mm; in-plane
resolution = 22.7 μm × 22.7 μm; number of averages N = 64. Both the MRI and histological images, depict three layers representing the superficial,
transitional, and radial zones. (B) T2 maps for engineered cartilage over a 4 week growth period. A monotonic increase of T2 is observed with time
in this experiment (Troken, A. J. et al., presented at the annual 2006 BMES Meeting, Chicago, IL, 11–14 Oct. 2006).

cause collagen is recognized by cellular enzymes and naturally
degraded (46). Bioreactor systems are also under investigation
in cartilage engineering; and an MR-compatible hollow fiber
bioreactor system was recently employed for the production
and development of three-dimensional hyaline cartilage from
isolated chondrocytes (47).
MRI of articular cartilage — High resolution MRI studies
are able to distinguish three characteristic zones in articular
cartilage: superficial, transitional and radial (for example, see
Figure 4). In each zone the MR signal reflects the interactions
between water and the distribution of collagen and proteoglycan. Identifying the structure of cartilage via MRI could
be an important step in assessing chondrogenesis. As an example, consider the results shown in Figure 4 taken from a
study by Othman and coworkers (48). In this figure a comparison is shown between a high resolution 11.7 T MR image of normal articular cartilage and the corresponding tissue histology section stained with safranin O. Over 4 weeks
the morphological appearance of developing cartilage in the
MR images showed a high correlation with the corresponding histological sections at all stages of development (48).
Thus, MRI can be expected to provide useful images for tissue-engineered cartilage.
Progress in monitoring tissue-engineered cartilage in vitro
— The first step in monitoring tissue-engineered cartilage is
to quantify cell growth and tissue development in vitro. Studies by Chen and associates (11), Greco and Spencer (49) and
Potter and coworkers (47, 50) used 9.4 T MRI to monitor hyaline cartilage growth in a hollow fiber bioreactor (HFBR).
All these researchers found a strong correlation between biochemical markers (e.g., tissue cellularity and extracellular matrix composition) and MR parameters (e.g., MTR, T1, T2, and
ADC). A novel feature of these studies was the use of a specially designed MR compatible bioreactor such that chondrocytes growing inside the HFBR could be monitored periodically over a period of weeks. Water content (via T1 and T2)

and two main components of the cartilage matrix, namely
proteoglycans (via Gd-DTPA enhanced imaging) and collagen (via MTR), were assayed. For example, the average T2
value decreased from 60 ± 4 ms at week 1 to 35 ± 5 ms at week
4; values comparable with those obtained at the same field
strength for natural articular cartilage by Nieminen and coworkers (51). In addition, the measured MTR value at week 1
was similar to that measured for a control collagen gel, while
the MTR value measured at week 4 was close to the value reported in the literature for bovine articular cartilage (52). In
the study by Potter and coworkers (50), tissue heterogeneity
was observed in both the MTR and T2 data while such heterogeneity is not seen in normal articular cartilage (51). Thus, the
MR measurements were able to identify poor tissue development. It should also be noted that electron spin resonance
(ESR) has been used by Spencer’s group to monitor oxygen
consumption in cartilage growing in a HFBR (53). Further
studies by Neves and coworkers (54) used MR microscopy
and MR spectroscopy at 9.4 T to examine the growth of bioartificial meniscal cartilage tissue in vitro in a perfusion bioreactor. Cell-seeding density, medium selection including
growth factors, and the application of physical stimuli, such
as pressure and flow-induced shear stress, were manipulated
to develop meniscal cartilages with properties approaching
those of the native tissue. For example, the diffusion into cartilage of the MR paramagnetic contrast agent Gd-DTPA from
the medium was used to assess the integrity of the developing zones (54). In this study a diffusion coefficient of 7 × 10−11
m2/s was reported for Gd-DTPA, which is similar to the 9. 2×
10−11 m2/s value measured by Foy and Blake in natural human articular cartilage (55).
Recent in vitro studies (56, 57) of MSCs embedded in gelatin and chondrocytes embedded in hydrogels used T2 maps
and changes in the apparent water diffusion coefficient to
characterize the development of engineered cartilage. An
example of the changes in T2 observed is shown in Figure 4
(Troken, A. J. et al., presented at the annual 2006 BMES Meet-
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ing, Chicago, IL, 11–14 Oct. 2006). These data illustrate the
successful use of MRI to monitor implant growth and integration with host cartilage.
Progress in monitoring tissue-engineered cartilage in vivo
— MRI techniques have also been used in vivo to characterize the development of tissue engineered cartilage (58], [59,
60). In a study by Watrin-Pinzano and coworkers (58), MR
was used to generate T2 maps during the repair of a focal patellar cartilage defect in a rat. In this study, alginate scaffolds,
with and without autologous chondrocytes, were implanted
at day 0 to repair rat patellar cartilage defects. The rats were
sacrificed sequentially (days 20, 40, and 60) after surgery, and
the patellae cartilage samples examined ex-vivo using MRI at
8.5 T. The T2 values derived from the MR images were found
to discriminate between the different types of neo-cartilage;
a result confirmed by histological analysis. In a related multinuclear NMR and MRI study by Keinan-Adamsky and associates (59) at 8.5 T using a pig model, the authors found
that the order and the density of collagen fibers in articular
cartilage increased from birth to maturity. This conclusion
was derived from the bi-exponential nature of T2 relaxation
in mature cartilage, as well as its orientational dependence
derived from NMR spectral splittings (59). Finally, a recent
study by Ramaswamy and coworkers (60, 61) used T2 relaxation data to assess the regrowth of cartilage in full-thickness
chondral defects (surgically created) in rabbits. These studies
demonstrate how NMR spectroscopic measurements T2 relaxation and MRI can be used to obtain structural and compositional information that contributes to a better understanding of the development of natural cartilage.
Adipose Tissue Engineering
Soft tissue defects also present challenges to the tissue engineers. In 2006, breast cancer was the third leading cause of
death in American women after heart disease and lung cancer; the cost of this disease was estimated to be over two
hundred billion dollars a year in 2005 (62). Breast cancer and
other cancers associated with adipose tissue leave patients
disfigured following surgery and X-ray treatment; therefore,
soft tissue reconstruction is an important clinical concern. In
addition to cancer patients, trauma patients undergoing reconstructive surgery could also benefit from improved soft
tissue reconstruction procedures.
Adipose tissue is a specialized connective tissue that
serves three functions: thermal insulation, energy regulation
and mechanical cushioning. The major component of white
adipose tissue is a loose association of lipid-filled cells (adipocytes), which are held in a framework of collagen fibers.
Approximately 70% of the weight of white adipose tissue is
lipid, with over 90% of the lipid in the form of triglycerides.
Compared with other mesenchymal tissues, adipose tissue is
less stiff and very heterogeneous.
Adipose tissue engineering via an autologous graft is the
technique preferred by clinicians. Such grafts are immune
compatible and convenient, but they require a donor site,
typically from the patient’s abdomen. Allogenic or xenogenic
grafts are also used in cases where there is the limited availability of autologous grafts. However, one major disadvantage of allogenic and xenogenic grafts is possible immune re-
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jection. Other strategies used for soft tissue reconstruction
include the insertion of synthetic materials (for example, silicone, saline bags), but such implants sometimes leak, degrade, or generate a foreign-material reaction (63).
Stem cell-based soft tissue engineering is currently under
investigation as an alternative grafting procedure (39). Adipose tissue is one of the types of connective tissue that can be
derived from MSCs (64). In this approach, MSCs are seeded
into the scaffold to establish a three-dimensional engineered
construct that provides a solid framework to simulate the extracellular matrix for cell attachment and proliferation. The
engineered cell-scaffold complexes are usually incubated in
a supportive physical and mechanical environment that also
provides essential nutrients, growth factors and tissue differentiation reagents (65). Current adipose tissue reconstruction
has the limitation that it is difficult to monitor graft growth
and development. As in the case of tissue engineered bone
and cartilage, adipose tissue development is hindered by the
absence of non-invasive imaging methods. MRI, which has
the capability of distinguishing between the hydrogen atoms
in lipids and those in water, is a tool that could be used to
monitor adipose tissue regrowth.
MRI of adipose tissue — Adipose tissue is a loose association
of lipid-filled cells (adipocytes), which are held in a framework
of collagen fibers. Even though adipose tissue is relatively
simple in structure, it is challenging to image using MRI. The
lipid and water protons behave as if they are located in two
different compartments, each with a different resonance frequency: water and lipid proton resonance differs by 225 Hz
at 1.5 T. In addition, the protons in lipid and water have separate relaxation times with the lipid protons relaxing via T1 and
T2 much faster than the water protons. However, these differences in frequency and relaxation times can be used to generate fat suppressed or water and fat suppressed images where
the lipid image is generally discarded (66).
Progress in monitoring tissue-engineered fat in vitro — MR
microscopy at 9.4 T with and without fat suppression was
used in a study by Potter and associates (20) to analyze the
fat component of tissue-engineered phalanges. The fractional
change in the image intensity was used to establish the spatial distribution of mobile lipid molecules within the phalange
constructs. Quantitative maps indicating adipose components
were acquired 10 and 38 weeks after implantation; the fat deposits observed at week 38 were similar to those observed in
histological sections. In a tissue engineering study by Marion and coworkers (Marion, N. et al., presented at the annual
2006 BMES Meeting, Chicago, IL, 11–14 Oct. 2006) the growth
stages of engineered fat were monitored using MR measurements of relaxation times and the water diffusion coefficient.
In this study of MSC derived adipogenic cells the T2 values
stayed unchanged for 4 weeks, but MR elastography measurements of the bulk modulus showed a significant decrease
(Figure 5). By week 4, for example, the shear modulus had decreased to less than one fourth of the initial value (5.8 kPa to
1.4 kPa). The decrease in shear stiffness indicates that the engineered adipogenic tissue becomes “softer” as adipogenic matrix production gradually increases. These results illustrate the
complementary role of MRI and MR elastography in assessing
the development of engineered tissue in vitro.
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Figure 5. (A) A comparison of histological and MR images of natural
fat and an MR image of engineered fat. For the engineered fat, the cells
were stained for oil red-O to indicate lipid synthesis as red and counterstained with hematoxylin to mark nuclei blue (25). (B) T2 relaxation
time and shear stiffness data for engineered fat. Although the MR images and T2 measurements were not able to differentiate between the
stages of adipogenesis, the elastography data showed a reduction in
stiffness suggesting lipid formation. All data are represented by average ± std (sample size n = 3).

Conclusions and Suggested Future Studies
Advances in tissue engineering will rely on improvements at all stages of the tissue development process:
choosing the cell source, selecting a biological scaffold, and
designing the incubation system. Imaging techniques (for
example, optical imaging, MRI, and micro-CT) are important tools for assessing tissue regeneration at each stage of
growth. Selection of the most appropriate imaging method
depends on several factors: the achievable signal-to-noise
ratio, the needed resolution, the presence or generation of
contrast, and the desire to visualize tissue structure in a
non-invasive manner. Ideally, imaging should provide the
tissue engineer with complete information on tissue composition, structure, and function. Realistically, no single
imaging modality can do all three. Light microscopy, for
example, has the highest resolution but requires tissue sampling, sectioning, and staining, whereas micro-CT is excellent at identifying tissue calcification and bone growth, but
has relatively poor soft tissue contrast, while MRI has the
highest sensitivity for visualizing soft tissue, but it is technically difficult, expensive and relatively slow in acquiring
high resolution images.
MRI, however, does provide a flexible, safe and non-invasive way of measuring many parameters associated with the
structural, biochemical and functional changes that occur in
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developing tissues. A schematic diagram illustrating the connection between tissue growth, tissue properties, and different MR-derived parameters is shown in Figure 6. Since tissue growth and development change the local environment
of the tissue water we need to observe these changes over
hours, days and weeks as the constructs develop into mature
tissues.
MRI has the capability of visualizing tissue development both during the initial in vitro stages of cell culture
and scaffold incubation and subsequently during tissue implantation development in vivo, where the final integration
of the implant—its structure and function—with surrounding tissues must be monitored. In the early proliferation
stages either the incubator or bioreactor, must be brought
to the MRI or the individual constructs must be removed
from the incubator to be imaged. Both steps have associated technical problems that are not fully resolved. For example, in the seeding step, the growth of cells in the scaffold must be optimized, and the porosity and diffusion of
water in the scaffold need to be examined periodically. This
requires sequential MR measurements. In addition, during
tissue growth and development, the compartmentalization
of tissue water changes; such changes alter the degree of
hydration, and can be visualized using MRI and quantified
by MR-derived measurements. In the case of engineered
bone, for example, water molecules become immobilized at
charged surfaces, reducing T1, while mineral deposition establishes local regions of solid bone altering the local magnetic susceptibility, reducing T2. For engineered cartilage,
collagen and proteoglycan deposition can be quantified by
observing changes in the diffusion coefficient and MT values. In both cases, the integration of tissue-engineered constructs with the host tissue in vivo needs to be evaluated
and the strength and stiffness of the implants assessed by
MR elastography. Post-implant monitoring using MRI is
crucial to ensure that the engineered constructs and regenerated tissues are functioning normally along with the host
tissue.
MRI is also capable of assessing changes in the shape and
size of the constructs that often occur during tissue development. Such changes likely reflect normal growth consolidation but they could also be due to non-uniform cell seeding
in the scaffold. Since cell seeding density is highly correlated with tissue development, better control of this process
is needed. This problem has been recognized by tissue engineers, as they work toward engineering tissues that retain
a pre-defined shape. In a similar manner MRI can be used
to identify and monitor the development of tissue structures
such as the internal layers of articular cartilage and the anisotropy of diffusion in cartilage and muscle.
Finally in vivo monitoring of the transitional region between implants and the surrounding tissues is an active area
of current research in tissue engineering and regenerative
medicine. New high resolution MRI protocols for assessing
cell proliferation in tissue engineering are a complement to
established optical and micro-CT methods. In the future, improved MR system capabilities should allow NMR spectroscopy and MRI to play an increasing role in tissue engineering, and ultimately speed the development of regenerative
medicine as an emerging clinical technique.
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Figure 6. Schematic description of the process of tissue engineering with the correspondence between MR techniques and tissue properties identified at each growth stage.
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